Initiator Pharma A/S - ESG Rating & Company Profile powered by AI
This analysis of Initiator Pharma A/S is prepared by All Street Sevva using advanced artificial intelligence. Browse to the bottom of this webpage for potential risks for Initiator Pharma A/S based on sector, location and size. This ESG rating for Initiator Pharma A/S represents the company's reporting of the UN SDGs.
Initiator Pharma A/S in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Initiator Pharma A/S | 8.0 | High |
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Initiator Pharma A/S have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Initiator Pharma A/S disclose current and historical energy intensity?
Sign up for free to unlockDoes Initiator Pharma A/S report the average age of the workforce?
Sign up for free to unlockDoes Initiator Pharma A/S reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Initiator Pharma A/S disclose its ethnicity pay gap?
Sign up for free to unlockDoes Initiator Pharma A/S disclose cybersecurity risks?
Sign up for free to unlockDoes Initiator Pharma A/S offer flexible work?
Sign up for free to unlockDoes Initiator Pharma A/S have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Initiator Pharma A/S disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Initiator Pharma A/S conduct supply chain audits?
Sign up for free to unlockDoes Initiator Pharma A/S disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Initiator Pharma A/S conduct 360 degree staff reviews?
Sign up for free to unlockDoes Initiator Pharma A/S disclose the individual responsible for D&I?
Sign up for free to unlockDoes Initiator Pharma A/S disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Initiator Pharma A/S disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Initiator Pharma A/S disclose water use targets?
Sign up for free to unlockDoes Initiator Pharma A/S have careers partnerships with academic institutions?
Sign up for free to unlockDid Initiator Pharma A/S have a product recall in the last two years?
Sign up for free to unlockDoes Initiator Pharma A/S disclose incidents of discrimination?
Sign up for free to unlockDoes Initiator Pharma A/S allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Initiator Pharma A/S issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Initiator Pharma A/S disclose parental leave metrics?
Sign up for free to unlockDoes Initiator Pharma A/S disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Initiator Pharma A/S disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Initiator Pharma A/S disclose the pay ratio of women to men?
Sign up for free to unlockDoes Initiator Pharma A/S support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Initiator Pharma A/S disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Initiator Pharma A/S reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Initiator Pharma A/S involved in embryonic stem cell research?
Sign up for free to unlockDoes Initiator Pharma A/S disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Initiator Pharma A/S disclose its waste policy?
Sign up for free to unlockDoes Initiator Pharma A/S report according to TCFD requirements?
Sign up for free to unlockDoes Initiator Pharma A/S disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Initiator Pharma A/S disclose energy use targets?
Sign up for free to unlockDoes Initiator Pharma A/S disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Initiator Pharma A/S have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Initiator Pharma A/S
These potential risks are based on the size, segment and geographies of the company.
Initiator Pharma A/S, a clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system. It develops IP2018, a monoamine reuptake inhibitor for the treatment of psychogenic erectile dysfunction; IPED2015 to treat patients suffering from organic erectile dysfunction; and IPTN2021 for targeting an orphan drug indication in severe neuropathic pain. The company's pre-clinical stage candidates include IPNP2015 for the treatment of chronic pain; and IPDP2015 for depression. Initiator Pharma A/S was incorporated in 2016 and is headquartered in Copenhagen, Denmark.